The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration’s requirements for EZPLAZ™ approval.
DEPT OF DEFENSE › DEFENSE HEALTH AGENCY (DHA) › DEFENSE HEALTH AGENCY
SAFE-PLASMA Protocol
Key facts
- Response deadline
- Nov 16, 2026
- 2:00 PM UTC-05:00
- Set-aside
- Not stated
- Notice type
- Sources sought
- Posted on SAM.gov
- Nov 10, 2026
- Archives Dec 1, 2026
Description
Contacts
Jamie Diggs · primary
Attachments
BidLookup records the links this notice gives. It has not downloaded or checked the files.
Record dates
- Posted on SAM.gov: Nov 10, 2026
- The agency’s publication date, as SAM.gov states it.
- First recorded by BidLookup: Nov 10, 2026
- The UTC day of the first read of SAM.gov’s listings that stored this notice.
- Last confirmed: Nov 10, 2026
- The UTC day of the latest read that still listed this notice. It does not mean the notice is unchanged or still open on SAM.gov now, and it is not the index’s last-read time.
Published by the agency on SAM.gov as notice 62847f8a042a4f0380c8e0ff90bb2de7. What these dates mean
Record
- Solicitation number
- HT9427-27-SSN-701
- Search the index for this number
- NAICS
- 541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Maryland 21702
- Contracting office
- FORT DETRICK, MD 21702
- SAM.gov notice ID
- 62847f8a042a4f0380c8e0ff90bb2de7